MedPath
NMPA Approval

Duloxetine Hydrochloride Enteric Capsules

国药准字HJ20240094

September 19, 2024

Drug Information

盐酸度洛西汀肠溶胶囊

胶囊剂

60mg(按C₁₈H₁₉NOS计)

化学药品

September 19, 2024

September 18, 2029

Company Information

Applicant Company

Unit- III, 22-110, I.D.A, Jeedimetla (V), Quthbullapur (M), Medchal-Malkajgiri (Dist.), 500055. Telangana state, India.

Manufacturing Company

Unit- III, 22-110, I.D.A, Jeedimetla (V), Quthbullapur (M), Medchal-Malkajgiri (Dist.), 500055. Telangana state, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸度洛西汀肠溶胶囊 - NMPA 批准文号 | MedPath